COVID-19's natural course among ambulatory monitored outpatients.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
12 05 2021
Historique:
received: 16 01 2021
accepted: 27 04 2021
entrez: 13 5 2021
pubmed: 14 5 2021
medline: 29 5 2021
Statut: epublish

Résumé

Research objective was to detail COVID-19's natural trajectory in relation to the Czech population's viral load. Our prospective detailed daily questionnaire-based telemonitoring study evaluated COVID-19's impact among 105 outpatients. In accordance with government quarantine requirements, outpatients were divided into a cohort with two negative tests at the end of the disease (40 patients) and a cohort with a new algorithm (65 patients) following a 14-day quarantine. Median follow-up differed significantly between the 2 groups (23 days vs. 16 days). Only 6% of patients were asymptomatic during the entire telemonitoring period. Another 13% of patients were diagnosed asymptomatic, as suspected contacts, yet later developed symptoms, while the remaining 81% were diagnosed as symptomatic on average 6 days following symptom onset. Telemonitoring enabled precise symptom status chronicling. The most frequently reported complaints were fevers, respiratory issues, and anosmia. Six patients were eventually hospitalized for complications detected early after routine telemonitoring. During the extended follow-up (median 181 days), anosmia persisted in 26% of patients. 79% of patients in the new quarantine algorithm cohort reported no symptoms on day 11 compared to just 56% of patients in the two negative test cohort upon first testing negative (median-19 days). The highest viral load occurred within 0-2 days of initial symptom onset. Both the PCR viral load and two consecutive PCR negative sample realizations indicated high interindividual variability with a surprisingly fluctuating pattern among 43% of patients. No definitive COVID-19 symptoms or set of symptoms excepting anosmia (59%) and/or ageusia (47%) were identified. No preexisting medical conditions specifically foreshadowed disease trajectory in a given patient. Without a PCR negativity requirement for quarantine cessation, patients could exhibit fewer symptoms. Our study therefore highlights the urgent need for routine ambulatory patient telemedicine monitoring, early complication detection, intensive mass education connecting disease demeanor with subsequent swift diagnostics, and, notably, the need to reevaluate and modify quarantine regulations for better control of SARS-CoV-2 proliferation.

Identifiants

pubmed: 33980931
doi: 10.1038/s41598-021-89545-1
pii: 10.1038/s41598-021-89545-1
pmc: PMC8115337
doi:

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

10124

Références

PLoS One. 2020 Dec 7;15(12):e0243523
pubmed: 33284865
N Engl J Med. 2020 Jun 25;382(26):2534-2543
pubmed: 32459916
Br J Haematol. 2021 Jan;192(2):e51-e54
pubmed: 33216364
Clin Infect Dis. 2020 Sep 18;:
pubmed: 32945846
J Infect Dis. 2020 Jun 11;221(12):1940-1947
pubmed: 32318703
Clin Infect Dis. 2020 Sep 28;:
pubmed: 32986798
Ear Nose Throat J. 2020 Nov;99(9):577-578
pubmed: 32436441
Telemed J E Health. 2020 Jul;26(7):850-852
pubmed: 32329659
Curr Allergy Asthma Rep. 2020 Oct 13;20(12):76
pubmed: 33048282
Otolaryngol Head Neck Surg. 2020 Dec;163(6):1144-1149
pubmed: 32600175
Laryngoscope. 2021 May;131(5):1095-1100
pubmed: 33404079
Lancet. 2020 Jun 27;395(10242):1973-1987
pubmed: 32497510
N Engl J Med. 2020 Nov 5;383(19):1813-1826
pubmed: 32445440
PLoS One. 2020 Nov 17;15(11):e0241955
pubmed: 33201896
J Infect. 2020 Dec;81(6):847-856
pubmed: 33049331
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246
Int J Infect Dis. 2020 Oct;99:266-268
pubmed: 32771632
JAMA. 2020 Apr 28;323(16):1574-1581
pubmed: 32250385
Sci Rep. 2020 Oct 15;10(1):17365
pubmed: 33060676
PLoS One. 2021 Mar 24;16(3):e0241875
pubmed: 33760821
J Infect. 2020 Jul;81(1):e33-e39
pubmed: 32294504
JAMA Intern Med. 2021 Jan 1;181(1):41-51
pubmed: 33080002
PLoS Med. 2020 Sep 22;17(9):e1003346
pubmed: 32960881
N Engl J Med. 2020 Jun 18;382(25):e102
pubmed: 32356626
Cell Mol Immunol. 2020 Nov;17(11):1119-1125
pubmed: 33037400
Nature. 2020 Sep;585(7825):339-341
pubmed: 32929257
Int J Infect Dis. 2021 Jan;102:70-72
pubmed: 33045427
Cochrane Database Syst Rev. 2020 Jul 7;7:CD013665
pubmed: 32633856
N Engl J Med. 2021 Mar 4;384(9):795-807
pubmed: 33306283
Infection. 2021 Feb;49(1):95-101
pubmed: 33025521
Am Fam Physician. 2020 Oct 15;102(8):478-486
pubmed: 33064422
J Med Internet Res. 2020 May 27;22(5):e19367
pubmed: 32412422
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Otolaryngol Head Neck Surg. 2020 Jul;163(1):114-120
pubmed: 32423357
PLoS One. 2020 Sep 17;15(9):e0239235
pubmed: 32941548
Rhinology. 2020 Dec 1;58(6):623-625
pubmed: 32812014
Eur Respir J. 2020 May 14;55(5):
pubmed: 32217650
J Infect Dis. 2020 Nov 9;222(11):1807-1815
pubmed: 32914853
Infect Control Hosp Epidemiol. 2020 Oct 20;:1-10
pubmed: 33077007
Respiration. 2020;99(9):748-754
pubmed: 32894853
Nature. 2020 Jul;583(7816):437-440
pubmed: 32434211
MMWR Morb Mortal Wkly Rep. 2020 Jul 31;69(30):993-998
pubmed: 32730238

Auteurs

Barbora Weinbergerova (B)

Department of Internal Medicine, Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic. Weinbergerova.Barbora@fnbrno.cz.

Jiri Mayer (J)

Department of Internal Medicine, Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic.

Stepan Hrabovsky (S)

Department of Internal Medicine, Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic.

Zuzana Novakova (Z)

Department of Internal Medicine, Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic.

Zdenek Pospisil (Z)

Department of Mathematics and Statistics, Faculty of Science, Masaryk University, Brno, Czech Republic.

Lucie Martykanova (L)

Institute of Health Information and Statistics of the Czech Republic, Prague, Czech Republic.
Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic.

Katerina Hortova (K)

Institute of Health Information and Statistics of the Czech Republic, Prague, Czech Republic.

Lucie Mandelova (L)

Institute of Health Information and Statistics of the Czech Republic, Prague, Czech Republic.

Karel Hejduk (K)

Institute of Health Information and Statistics of the Czech Republic, Prague, Czech Republic.
Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic.

Renata Chloupková (R)

Institute of Health Information and Statistics of the Czech Republic, Prague, Czech Republic.
Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic.

Michal Pospisil (M)

Department of Nursing and Midwifery, Faculty of Medicine, Masaryk University, Brno, Czech Republic.

Martina Doubkova (M)

Department of Respiratory Diseases, Masaryk University and University Hospital Brno, Brno, Czech Republic.

Vladimir Marek (V)

Department of Internal Medicine, Geriatrics and Practical Medicine, Masaryk University and University Hospital Brno, Brno, Czech Republic.

Renata Novotna (R)

General Practitioner's Office, Berkova 2390/107, 61200, Brno, Czech Republic.

Martin Dolecek (M)

Department of Anesthesiology and Intensive Care Medicine, Masaryk University and University Hospital Brno, Brno, Czech Republic.

Hana Matejovska Kubesova (HM)

Department of Internal Medicine, Geriatrics and Practical Medicine, Masaryk University and University Hospital Brno, Brno, Czech Republic.

Kristian Brat (K)

Department of Respiratory Diseases, Masaryk University and University Hospital Brno, Brno, Czech Republic.

Radana Parizkova (R)

Department of Infectious Diseases, Masaryk University and University Hospital Brno, Brno, Czech Republic.

Petr Husa (P)

Department of Infectious Diseases, Masaryk University and University Hospital Brno, Brno, Czech Republic.

Marek Mechl (M)

Department of Radiology and Nuclear Medicine, Masaryk University and University Hospital Brno, Brno, Czech Republic.

Zdenek Kral (Z)

Department of Internal Medicine, Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic.

Martina Lengerova (M)

Department of Internal Medicine, Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH